Literature DB >> 2193480

Chromosomal evolution and tumor progression in a myxoid liposarcoma.

C Orndal1, N Mandahl, A Rydholm, M Nilbert, S Heim, M Akerman, F Mitelman.   

Abstract

A myxoid liposarcoma showed macroscopic, histologic, and cytogenetic heterogeneity. In one of three myxoid nodules and in the surrounding lipoma-like tumor tissue, the translocation t(12;16)(q13;p11), known to be specific for myxoid liposarcoma, was found as the sole chromosomal abnormality. In the other two nodules, additional rearrangements involving chromosomes 1, 12, and 16 were found. These aberrations were probably secondary to the primary t(12;16), and are cytogenetic evidence of clonal evolution. The complex chromosome aberrations were present in those tumor parts that had more malignant histology, indicating that the acquisition of secondary chromosomal aberrations parallels the histologic manifestations of tumor progression.

Entities:  

Mesh:

Year:  1990        PMID: 2193480     DOI: 10.3109/17453679009006497

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  3 in total

Review 1.  Running GAGs: myxoid matrix in tumor pathology revisited: what's in it for the pathologist?

Authors:  Stefan M Willems; Malgorzata Wiweger; J Frans Graadt van Roggen; Pancras C W Hogendoorn
Journal:  Virchows Arch       Date:  2009-08-25       Impact factor: 4.064

2.  Chromosome aberrations and cytogenetic intratumor heterogeneity in chondrosarcomas.

Authors:  C Orndal; N Mandahl; A Rydholm; H Willén; O Brosjö; F Mitelman
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

3.  Cytogenetic evolution in primary tumors, local recurrences, and pulmonary metastases of two soft tissue sarcomas.

Authors:  C Orndal; N Mandahl; H Willén; A Rydholm; F Mitelman
Journal:  Clin Exp Metastasis       Date:  1993-09       Impact factor: 5.150

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.